| Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
|---|
| Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
|---|
| Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
|---|
Anbio Biotechnology (NASDAQ:NNNN) IPO will take place February, 19 on the NASDAQ exchange under the ticker NNNN.
The company is offering shares at an expected price between $5.00 and $6.00 per share with an insider lock-up period of 180 days ending on August 18, 2025.
See also: Benzinga IPO Calendar
Anbio Biotechnology is dedicated to the advancement of medical technology and the provision of in vitro diagnostics (IVD) products. unwavering commitment lies in transforming the diagnostics landscape on a global scale, fostering a paradigm shift towards personalized and decentralized diagnostic solutions.
See also: Benzinga's Most Shorted Stocks
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Posted In: NNNN
